EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients

Norbert Tóth, Réka Brubel, Attila Bokor, Ágnes Kemény iD, Nelli Farkas iD, Tibor Pál, Zsuzsanna Helyes, Krisztina Pohóczky

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26146695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Norbert Tóth und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, 7624 Pécs, Hungary. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Endometriosis, Epidermal Growth Factor, Intramolecular Oxidoreductases. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Hungarian Research Network (HUN-REN), Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometriosis is the extrauterine engraftment of endometrium-like tissue, causing chronic pain. Complex sensory–vascular–immune interactions, including growth factors, cytokines, and neuropeptides, are implicated in its pathophysiology, but the mechanisms remain unknown. Here, epidermal growth factor (EGF), vascular endothelial growth factor, interleukins (IL-1β, IL-6, IL-8), macrophage migration inhibitory factor (MIF), calcitonin gene-related peptide, and somatostatin were measured in the serum of endometriosis patients with different disease severities, menstruation cycle- and pharmacotherapy-related hormonal status compared with controls. Mediator levels in deep-infiltrating rectosigmoid nodules were also compared with those in non-endometriotic colon tissues. Pain was assessed by the visual analogue scale. Serum EGF was significantly lower in mild endometriosis and in the secretory phase. MIF and IL-6 were higher in stage I–IV endometriosis, with MIF also higher in the secretory phase and in patients not receiving oral contraceptives. Somatostatin was lower in mild endometriosis than that in healthy individuals and the severe endometriosis group. No tissue-level differences were found. A strong positive correlation between serum EGF and somatostatin levels and dysmenorrhea and dysuria was detected in mild cases. It is concluded that certain serum alterations may be related to severity- and hormone status-dependent endometriosis mechanisms, but their diagnostic/prognostic value seems to be limited due to variability and lack of specificity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage Migration-Inhibitory FactorsEndometriosisEpidermal Growth FactorIntramolecular OxidoreductasesHumansFemaleAdultSeverity of Illness IndexSomatostatinBiomarkersCase-Control StudiesMiddle Aged

Stichwörter der Autor:innen

calcitonin gene-related peptideendometriosisimmunoassayinterleukinsmacrophage migration inhibitory factorpain assessmentsomatostatinsystemic inflammationtumor necrosis factor alphavisual analogue scale

Substanzen

Macrophage Migration-Inhibitory FactorsMIF protein, humanEpidermal Growth FactorIntramolecular OxidoreductasesSomatostatinBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacology and Pharmacotherapy, Medical School, University of Pécs, 7624 Pécs, Hungary.
  • 1st Department of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.
  • Department of Physiology and Biochemistry, University of Veterinary Medicine, 1078 Budapest, Hungary.
  • Department of Medical Biology and Central Electron Microscope, Medical School, University of Pécs, 7624 Pécs, Hungary.
  • Institute of Bioanalysis, Medical School, University of Pécs, 7624 Pécs, Hungary.
  • Hungarian Research Network, Chronic Pain Research Group (HUN-REN-PTE), 7624 Pécs, Hungary.

ORCID-Profile: Ágnes Kemény, Nelli Farkas

Förderung

  • National Research, Development and Innovation Office
  • Hungarian Research Network (HUN-REN)
  • Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund
  • "Dr. Szolcsányi János" GYTK KA-2024-02
  • Hungarian Academy of Sciences
  • Chronic Pain Research Group
  • Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund of Hungary
  • ÁOK-KA Dr. Szolcsányi János research fund

Zitieren

APA

Tóth, N., Brubel, R., Bokor, A., Kemény, Á., Farkas, N., Pál, T., Helyes, Z., & Pohóczky, K. (2025). Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146695

Vancouver

Tóth N, Brubel R, Bokor A, Kemény Á, Farkas N, Pál T, et al. Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146695

BibTeX
@article{Tth2025,
  author = {Tóth, Norbert and Brubel, Réka and Bokor, Attila and Kemény, Ágnes and Farkas, Nelli and Pál, Tibor and Helyes, Zsuzsanna and Pohóczky, Krisztina},
  title = {Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26146695}
}
Kostenlos starten →